Pharmaceutical Research & Consulting, Inc.

Research Facebook Instagram

CURRENTLY ENROLLING TRIALS:

 
Chronic Rhinosinusitis
(investigational medication)
click for PDF
Asthma
(investigational medication)
click for PDF
Chronic Cough
(investigational medication)
click for PDF
Bellus
(Cough Study)
click for PDF

Pharmaceutical Research & Consulting, Inc. (PRC) is a clinical research facility led by Dr. Gary Gross and Dr. Michael Ruff. It is committed to studying new treatments and improving current treatments for the benefit of people affected by these diseases. PRC conducts adult and pediatric clinical trials in the following areas:

  • Asthma
  • Allergic rhinitis (allergies)
  • Bronchitis
  • Chronic obstructive pulmonary disease (COPD)
  • Non-allergic rhinitis
  • Sinusitis
  • Urticaria (hives)
  • Chronic cough
  • Peanut allergy
  • Nasal Polyps

PRC is helping to develop new treatments for these diseases and is strictly regulated by the U.S. Food and Drug Administration (FDA).

PRC has been conducting clinical trials since 1979 and employs 4 clinical research coordinators who coordinate these clinical trials under the supervision of Dr. Gross and Dr. Ruff. Since 1979 we have successfully completed over 350 Phase II-IV clinical research trials.

IF YOU ARE INTERESTED IN LEARNING MORE ABOUT OUR RESEARCH STUDIES, PLEASE CONTACT US AT (214) 361-5555 OR EMAIL US AT rebecca.lindsey@daac-prc.com